11 – 20 of 229
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer : a long-term follow-up of the SweBCG91RT randomized trial
(
- Contribution to journal › Article
-
Mark
Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
(
- Contribution to journal › Article
-
Mark
The implementation of NILS : A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
(
- Contribution to journal › Article
- 2022
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Article
-
Mark
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
(
- Contribution to journal › Article
-
Mark
The NILS Study Protocol : A Retrospective Validation Study of an Artificial Neural Network Based Preoperative Decision-Making Tool for Noninvasive Lymph Node Staging in Women with Primary Breast Cancer (ISRCTN14341750)
(
- Contribution to journal › Article
-
Mark
Prediction of node negative breast cancer and high disease burden through image analysis software on mammographic images and clinicopathological data
2022)(
- Contribution to conference › Abstract
-
Mark
One-year recovery from breast cancer : Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life
(
- Contribution to journal › Article
-
Mark
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
(
- Contribution to journal › Article
-
Mark
Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)
(
- Contribution to journal › Article